Clinical Trials
4 trialsNCT00942825 2017-05-24
CBP08-02
CanBas Co. Ltd.
Phase 2 Completed
NCT00753714 2016-10-17
ZELIG
Sanofi
Phase 2 Completed
NCT00799240 2014-11-07
IMPACT
University of Kansas Medical Center
Phase 2 Completed
NCT00005906 2010-04-30
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed